44
Participants
Start Date
December 15, 2023
Primary Completion Date
September 23, 2024
Study Completion Date
December 22, 2024
Lactic Acid
patients will be treated with MN combined with lactic acid solution 1%. Lactic acid solution 88% concentration PH (6.84), diluted with distilled water to have a final concentration of 1%
vit D
patients will be treated with MN combined with topical application of vitamin D3 (an aqueous preparation of cholecalciferol (2.5 mg/ ml), The maximum total amount of vitamin D3 injected into a patient in every session will be 2.5 mg (1 ml)
Triamcinolone Acetonide
patients will be treated with MN combined with triamcinolone acetonide injectable suspension (Epirelefan®, 40mg/ ml, Eipico, Egypt) (10 mg/ml) will be used in a dose of 0.1 ml/cm2 area
Saline
patients will be treated with MN combined with normal saline 0.9%
RECRUITING
Rana Ehab, Zagazig
Zagazig University
OTHER_GOV